Recruiting OBSERVATIONAL NCT06661668

Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis

Laparoscopic Implantation of a Gastric Pacemaker is a Low-complication Alternative for Gastroparesis

Sponsor: Enterra Medical, Inc.

Conditions Gastroparesis Gastroparesis Nondiabetic Gastroparesis Postoperative Gastroparesis With Diabetes Mellitus

Interventions Gastric pacemaker (Enterra system) implantation

Updated 2 times since 2024 Last updated: Aug 6, 2025 Started: Jan 1, 2023 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Gastroparesis and Gastroparesis Nondiabetic and is currently actively recruiting participants. Enterra Medical, Inc. leads this study, which shows 2 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Nov 2024 — Sep 2025 [monthly]

Recruiting

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Enterra Medical, Inc.
Evangelic Hospital Kalk Cologne

Data source: Evangelic Hospital Kalk Cologne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cologne, Germany